Peisker A, Raschke GF, Schultze-Mosgau  S. Management of dental extraction in patients with Haemophilia A and B: A report of 58 extractions. Med Oral Patol Oral Cir Bucal. 2014 Jan 1;19 (1):e55-60.

 

 

doi:10.4317/medoral.19191

http://dx.doi.org/doi:10.4317/medoral.19191

 

 

 

1. Skinner MW. Treatment for all: a vision for the future. Haemophilia. 2006;12:169-173.
http://dx.doi.org/10.1111/j.1365-2516.2006.01280.x
PMid:16684013

 

2. Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003; 361:1801-1809.
http://dx.doi.org/10.1016/S0140-6736(03)13405-8

 

3. White GC 2nd, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Factor VIII and Factor IX Subcommittee. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001;85:560.
PMid:11307831

 

4. Hermans C, Altisent C, Batorova A, Chambost H, De Moerloose P, Karafoulidou A, et al. European Haemophilia Therapy Standardisation Board. Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations. Haemophilia. 2009;15:639-58.
http://dx.doi.org/10.1111/j.1365-2516.2008.01950.x
PMid:19444969

 

5. Stubbs M, Lloyd J. A protocol for the dental management of von Willebrand's disease, Haemophilia A and Haemophilia B. Aust Dent J. 2001;46:37-40.
http://dx.doi.org/10.1111/j.1834-7819.2001.tb00272.x

 

6. Zanon E, Brandolin B, Saggiorato G, Bacci C. Complex dental extractions in a patient with severe Haemophilia A and inhibitors treated with activated prothrombin complex concentrate. Blood Transfus. 2012;10:225-7.
PMid:22337269 PMCid:PMC3320785

 

7. Hewson ID, Makhmaloaf P. Management of third molar removal with a single dose of recombinant Factor IX (BeneFIX) and local measures in severe Haemophilia B. Aust Dent J. 2010;55:322-4.
http://dx.doi.org/10.1111/j.1834-7819.2010.01242.x
PMid:20887522

 

8. Björkman S, Berntorp E. Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia. Clin Pharmacokinet. 2001;40:815-32.
http://dx.doi.org/10.2165/00003088-200140110-00003
PMid:11735604

 

9. Poon MC, Lillicrap D, Hensman C, Card R, Scully MF. Recombinant FIX recovery and inhibitor safety: a Canadian post-licensure surveillance study. Thrombosis and Hemostasis. 2002;87:431-5.
PMid:11916075

 

10. Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia. Guidelines for the management of hemophilia. Haemophilia. 2013;19:1-47.
http://dx.doi.org/10.1111/j.1365-2516.2012.02909.x
PMid:22776238

 

11. Sultan Y. Prevalence of inhibitors in a population of 3435 hemophilia patients in France. Thromb Haemost. 1992;67:600-2.
PMid:1509398

 

12. Hay CR, Ludlam CA, Colvin BT, Hill FG, Preston FE, Wasseem N, et al. Factor VIII inhibitors in mild and moderate severity haemophilia A. Thromb Haemost. 1998;79:762-6.
PMid:9569189

 

13. Schwaab R, Brackmann HH, Meyer C, Seehafer J, Kirchgesser M, Haack A, et al. Haemophilia A: Mutation type determines risk of inhibitor formation. Thromb Haemost. 1995;74:1402-6.
PMid:8772209

 

14. Addiego J, Kasper C, Abildgaard C, Hilgartner M, Lusher J, Glader B, et al. Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII. Lancet. 1993;342:462-4.
http://dx.doi.org/10.1016/0140-6736(93)91593-B

 

15. Hay CR, Ollier W, Pepper L, Cumming A, Keeney S, Goodeve AC, et al. HLA class II profile: Aweak determinant of factor VIII inhibitor development in severe haemophilia A. Thromb Haemost. 1997;77:234-7.
PMid:9157572

 

16. Oldenburg J, Picard JK, Schwaab R, Brackmann HH, Tuddenham EG, Simpson E. HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors to factor VIII. Thromb Haemost. 1997;77:238-242.
PMid:9157573

 

17. O'Connell N, Mc Mahon C, Smith J, Khair K, Hann I, Liesner R, et al. Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors. Br J Haematol. 2002;116:632-5.
http://dx.doi.org/10.1046/j.0007-1048.2001.03324.x
PMid:11849223

 

18. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997;90:2515-21.
PMid:9326215

 

19. Franchini M, Zaffanello M, Lippi G. The use of desmopressin in mild hemophilia A. Blood Coagul Fibrinolysis. 2010;21:615-9.
PMid:20829683

 

20. Castaman G. Desmopressin for the treatment of haemophilia. Haemophilia. 2008;14 Suppl 1:15-20.
http://dx.doi.org/10.1111/j.1365-2516.2007.01606.x
PMid:18173690

 

21. Piot B, Sigaud-Fiks M, Huet P, Fressinaud E, Trossaërt M, Mercier. Management of dental extractions in patients with bleeding disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:247-50.
http://dx.doi.org/10.1067/moe.2002.121431
PMid:11925531

 

22. Frachon X, Pommereuil M, Berthier AM, Lejeune S, Hourdin-Eude S, Quéro J, et al. Management options for dental extraction in hemophiliacs: a study of 55 extractions (2000–2002). Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:270-5.
http://dx.doi.org/10.1016/j.tripleo.2004.06.071
PMid:15716831

 

23. Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19:1-47.
http://dx.doi.org/10.1111/j.1365-2516.2012.02909.x
PMid:22776238

 

24. Franchini M, Rossetti G, Tagliaferri A, Pattacini C, Pozzoli D, Lorenz C, et al. Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia Centers. Haemophilia. 2005;11:504-9.
http://dx.doi.org/10.1111/j.1365-2516.2005.01132.x
PMid:16128895

 

25. Rayen R, Hariharan VS, Elavazhagan N, Kamalendran N, Varadarajan R. Dental management of hemophiliac child under general anesthesia. J Indian Soc Pedod Prev Dent. 2011;29:74-9.
http://dx.doi.org/10.4103/0970-4388.79954
PMid:21521925

 

26. Kim JC, Choi SS, Wang SJ, Kim SG. Minor complications after mandibular third molar surgery: type, incidence, and possible prevention. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:4-11.
http://dx.doi.org/10.1016/j.tripleo.2005.10.050
PMid:16876044

 

27. Jackson MR, McPhee MJ, Drohan WN, Alving BM. Fibrin sealant: current and potential clinical applications. Blood Coagul Fibrinolysis. 1996;7:737-46.
http://dx.doi.org/10.1097/00001721-199611000-00001
PMid:9034553

 

28. Al-Belasy FA, Amer MZ. Hemostatic effect of n-butyl-2-cyanoacrylate (histoacryl) glue in warfarin-treated patients undergoing oral surgery. J Oral Maxillofac Surg. 2003;61:1405-9.
http://dx.doi.org/10.1016/j.joms.2002.12.001

 

29. Wagner WR, Pachence JM, Ristich J, Johnson PC. Comparative in vitro analysis of topical hemostatic agents. J Surg Res. 1996;66:100-108.
http://dx.doi.org/10.1006/jsre.1996.0379
PMid:9024819

 

30. Zanon E, Martinelli F, Bacci C, Zerbinati P, Girolami A. Proposal of a standard approach to dental extraction in haemophilia patients. A case-control study with good results. Haemophilia. 2000;6:533-6.
http://dx.doi.org/10.1046/j.1365-2516.2000.00423.x
PMid:11012698